Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells

被引:526
作者
Heller, F
Fuss, IJ
Nieuwenhuis, EE
Blumberg, RS
Strober, W
机构
[1] NIAID, Mucosal Immun Sect, Clin Invest Lab, NIH, Bethesda, MD 20892 USA
[2] Harvard Univ, Sch Med, Div Gastroenterol, Brigham & Womens Hosp, Boston, MA 02115 USA
[3] Royal Netherland Acad Arts & Sci, Ter Meulen Fund, Amsterdam, Netherlands
关键词
D O I
10.1016/S1074-7613(02)00453-3
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Oxazolone colitis (OC) is an experimental colitis that has a histologic resemblance to human ulcerative colitis. Here we show that IL-13 production is a significant pathologic factor in OC since its neutralization by IL-13Ralpha2-Fc administration prevents colitis. We further show that OC is mediated by NK-T cells since it can be induced neither in mice depleted of NK-T cells nor in mice that cannot present antigen to NK-T cells and mice lacking an NK-T cell-associated TCR. Finally, we show that NK-T cells are the source of the IL-13, since they produce IL-13 upon stimulation by a-galactosylceramide, an NK-T cell-specific antigen. These data thus describe a cellular mechanism underlying an experimental colitis that may explain the pathogenesis of ulcerative colitis.
引用
收藏
页码:629 / 638
页数:10
相关论文
共 50 条
  • [31] Park SH, 1998, J IMMUNOL, V160, P3128
  • [32] Parronchi P, 1997, AM J PATHOL, V150, P823
  • [33] Roark JH, 1998, J IMMUNOL, V160, P3121
  • [34] SARTOR RB, 1995, GASTROENTEROL CLIN N, V24, P475
  • [35] Activation of natural killer T cells by α-galactosylceramide in the presence of CD1d provides protection against colitis in mice
    Saubermann, LJ
    Beck, P
    De Jong, YP
    Pitman, RS
    Ryan, MS
    Kim, HS
    Exley, M
    Snapper, S
    Balk, SP
    Hagen, SJ
    Kanauchi, O
    Motoki, K
    Sakai, T
    Terhorst, C
    Koezuka, Y
    Podolsky, DK
    Blumberg, RS
    [J]. GASTROENTEROLOGY, 2000, 119 (01) : 119 - +
  • [36] SCHEIFFELE F, 2002, CURRENT PROTOCOLS IM, V4
  • [37] Immunoglobulin E production in the absence of interleukin-4-secreting CD1-dependent cells
    Smiley, ST
    Kaplan, MH
    Grusby, MJ
    [J]. SCIENCE, 1997, 275 (5302) : 977 - 979
  • [38] CD1-reactive natural killer T cells are required for development of systemic tolerance through an immune-privileged site
    Sonoda, KH
    Exley, M
    Snapper, S
    Balk, SP
    Stein-Streilein, J
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (09) : 1215 - 1225
  • [39] CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells
    Spada, FM
    Koezuka, Y
    Porcelli, SA
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (08) : 1529 - 1534
  • [40] Spada FM, 2000, EUR J IMMUNOL, V30, P3468, DOI 10.1002/1521-4141(2000012)30:12<3468::AID-IMMU3468>3.0.CO